ID: ALA483140

Max Phase: Preclinical

Molecular Formula: C21H19FN2O5

Molecular Weight: 398.39

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(CCc1noc2c1ccc1c(F)c(O)ccc12)NC1=C(C(=O)O)CCCC1

Standard InChI:  InChI=1S/C21H19FN2O5/c22-19-11-5-6-13-16(24-29-20(13)12(11)7-9-17(19)25)8-10-18(26)23-15-4-2-1-3-14(15)21(27)28/h5-7,9,25H,1-4,8,10H2,(H,23,26)(H,27,28)

Standard InChI Key:  JCDKFNXXFDJBPG-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 398.39

Molecular Weight (Monoisotopic): 398.1278

AlogP: 3.79

#Rotatable Bonds: 5

Polar Surface Area: 112.66

Molecular Species: ACID

HBA: 5

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 3.07

CX Basic pKa:

CX LogP: 2.46

CX LogD: -1.18

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.60

Np Likeness Score: -0.43

References

1. Shen HC, Ding FX, Deng Q, Wilsie LC, Krsmanovic ML, Taggart AK, Carballo-Jane E, Ren N, Cai TQ, Wu TJ, Wu KK, Cheng K, Chen Q, Wolff MS, Tong X, Holt TG, Waters MG, Hammond ML, Tata JR, Colletti SL..  (2009)  Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.,  52  (8): [PMID:19309152] [10.1021/jm900151e]

Source

Source(1):

• Scientific Literature